Kiniksa Pharmaceuticals International, plc
KNSA
$33.70
$0.130.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 556.29% | 148.23% | -135.22% | 8.39% | -126.10% |
| Total Depreciation and Amortization | -16.74% | -25.97% | -25.93% | -33.83% | -28.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.67% | -6.37% | 138.43% | -76.83% | 238.95% |
| Change in Net Operating Assets | 83.19% | -81.36% | 618.48% | -49.12% | -66.19% |
| Cash from Operations | 443.54% | 459.92% | 333.99% | -113.16% | 238.07% |
| Capital Expenditure | -- | -17.86% | -244.64% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.06% | -300.88% | 541.34% | 48.23% | -231.64% |
| Cash from Investing | 91.70% | -301.93% | 538.38% | 48.29% | -231.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,022.91% | -20.38% | 184.22% | 467.35% | 96.71% |
| Repurchase of Common Stock | -55.90% | -8.14% | -120.61% | -145.43% | -213.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,110.11% | -23.39% | 208.20% | 1,111.78% | -212.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.49% | -179.85% | 973.05% | -136.02% | -230.86% |